)
)
Sage Therapeutics Investor Relations Material
Latest events
Q3 2024
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics, Inc., operates as a biopharmaceutical company, which focuses on the development and commercialization of medicines to treat central nervous system disorders. Its products include, for example, SAGE-547 and SAGE-217.
Key slides for Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
SAGE
Country
🇺🇸 United States